Author/Authors :
Wang, Shuxia Departments of Cadre Clinic and Cardiology - Chinese People’s Liberation Army General Hospital , Song, Kangxing Departments of Cadre Clinic and Cardiology - Chinese People’s Liberation Army General Hospital , Guo, Xiyun Departments of Cadre Clinic and Cardiology - Chinese People’s Liberation Army General Hospital , Xue, Hao Departments of Cadre Clinic and Cardiology - Chinese People’s Liberation Army General Hospital , Wang, Nina Department of Plastic Surgery - Qingdao Second Nursing Hospital of Ji’nan Military Area Command , Chen, Jingzhou Department of Cardiology - Key Laboratory for Clinical Cardiovascular Genetics - Ministry of Education Cardiovascular Institute - Fuwai Hospital - Beijing union Medical College - Beijing, China , Zou, Yubao Department of Cardiology - Key Laboratory for Clinical Cardiovascular Genetics - Ministry of Education Cardiovascular Institute - Fuwai Hospital - Beijing union Medical College - Beijing, China , Sun, Kai Department of Cardiology - Key Laboratory for Clinical Cardiovascular Genetics - Ministry of Education Cardiovascular Institute - Fuwai Hospital - Beijing union Medical College - Beijing, China , Wang, Hu Department of Cardiology - Key Laboratory for Clinical Cardiovascular Genetics - Ministry of Education Cardiovascular Institute - Fuwai Hospital - Beijing union Medical College - Beijing, China , He, Jinggui , Hui, Rutai Department of Cardiology - Key Laboratory for Clinical Cardiovascular Genetics - Ministry of Education Cardiovascular Institute - Fuwai Hospital - Beijing union Medical College - Beijing, China
Abstract :
Background: The association of metabolic syndrome (MS) with left ventricular (LV) hypertrophy is controversial. The objective of our
study was to investigate the influence of MS on LV mass and geometry in community-based hypertensive patients among Han Chinese.
Materials and Methods: This study included 1733 metabolic syndrome patients according to the International Diabetes Federation
(IDF) definition and 2373 non-MS hypertension patients. LV hypertrophy was diagnosed by the criteria of LV mass ≥49.2 g/m2.7 for
men and 46.7 g/m2.7 for women. LV geometric patterns (normal, concentric remodeling, concentric or eccentric hypertrophy) were
calculated according to LV hypertrophy and relative wall thickness. Logistic regression analysis was used to determine odds ratio
(OR) and 95% confidence interval (CI) of MS for LV hypertrophy and LV geometry abnormality. Results: The LV mass and LV mass
index were higher in the MS group than in the non-MS group. In multiple adjusted models. LV mass index, LV mass, interventricular
septum, and post wall were raised with the increased number of MS disorders. MS was associated with increased LV hypertrophy
risk (unadjusted or 1.38; 95% CI 1.21-1.57); age, sex, and blood pressure (BP; adjusted or 1.39; 95% CI 1.22-1.59). MS was also
associated with increased risk of eccentric hypertrophy in male and female patients. MS was only associated with increased risk of
concentric hypertrophy in female patients; and MS was not associated with concentric remodeling. Conclusion: LV mass and LV
mass index were associated with the increased number of MS disorders in the Chinese community-based hypertensive population.
MS was not only associated with increased LV hypertrophy risk, but also associated with concentric and eccentric LV geometry
abnormality, especially in females.
Keywords :
metabolic syndrome (MS) , LV hypertrophy , left ventricular (LV) geometry abnormality , Hypertension